# SEREVENT
> **NDA020236** · New Drug Application · Sponsor: GLAXOSMITHKLINE · Approved 1994-02-04
## Drug
- **FDA Application Number:** NDA020236
- **Application type:** New Drug Application
- **Brand name:** SEREVENT
- **Generic name:** Salmeterol Xinafoate
- **Active ingredients:** SALMETEROL XINAFOATE
- **Dosage form:** AEROSOL, METERED
- **Route:** INHALATION
- **Marketing status:** Discontinued
- **Sponsor:** GLAXOSMITHKLINE
- **First approval:** 1994-02-04
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020236)
---
*AI Analytics · CC0 1.0*